Biofidelity: Scientific Advisory Board

Biofidelity has announced the initial members of its newly-formed scientific advisory board, which include Mace Rothenberg, former chief medical officer at Pfizer; Hesham Abdullah, head of oncology global clinical development at GlaxoSmithKline; Jerald Radich, professor & endowed chair at the Fred Hutchinson Cancer Research Center; Andrea Conners, executive director of the Patient Empowerment Network; and Phylicia Woods, executive director of the Cancer Policy Institute and Cancer Support Community.

Biofidelity's SAB will help guide the development of the firm's portfolio of molecular diagnostic products based on the ASPYRE technology, which enables simple, decentralized multi-gene testing in a fraction of the time and at a fraction of the cost of other technologies.